Wavelight plus uses Ray Tracing Technology to create a Digital Eye Twin, a highly detailed 3D model of each patient’s eye

Alcon announced the launch of wavelight plus, India’s first fully personalised Laser-Assisted In Situ Keratomileusis (LASIK) treatment. Alcon is a leader in refractive vision correction and its next-generation wavelight plus technology introduces a new era of precision in refractive surgery, with unprecedented levels of personalization offering patients outstanding visual outcomes with minimal risk and excellent predictability. Wavelight plus has received Central Drugs Standard Control Organisation (CDSCO) India approval, CE Mark and recently received US Food and Drug Administration (FDA) approval.12

Amar Vyas, Country Head, Alcon India. “Wavelight plus is a breakthrough in personalized vision correction, designed for the younger generation who refuse to be limited by spectacles. We are excited to offer Alcon’s latest innovation in vision correction in India. This launch also marks a new chapter in Alcon’s longstanding commitment to laser eye surgery, as we enable surgeons in India for the first time to deliver a fully personalised procedure, tailored to every patient’s complete eye system."

Unlike conventional Lasik treatment, wavelight plus uses Ray Tracing Technology to create a Digital Eye Twin, a highly detailed 3D model of each patient’s eye. This allows surgeons to simulate, test and optimise a fully customised treatment plan before surgery, ensuring a high level of accuracy and personalised vision correction. By considering the complete optical system rather than just the cornea, this innovation enhances surgical precision, safety and visual outcomes, often enabling patients to achieve vision beyond 20/20.